Lonza Makes Carnipure® L-Carnitine Available for Direct Sales in India

May 30, 2019

Mumbai (IN), 28 May 2019 Lonza announced today that its Carnipure® L-Carnitine ingredient is now available for sale directly in India. Previously only available to nutritional supplement manufacturers via direct importation, Lonza’s Carnipure® brand offers a high-quality grade of L-Carnitine in both crystalline and tartrate forms, which are ideal for use in nutritional supplements, foods and beverages.

Gilles Razzauti, Head of the Asia Pacific region for Lonza Consumer Health & Nutrition, said: “Backed by more than three decades of robust scientific analysis and discovery, Carnipure® L-Carnitine is a leading sports nutrition ingredient across the globe. Thanks to the central role L-Carnitine plays in metabolism, the Carnipure® brand has a broad array of additional applications, including energy, weight management and fertility.

“With significant sales and growing interest in the ingredient throughout the region, we have taken the important step to make this ingredient available directly here in India. The aim is to not only save our customers valuable import time, but also help them more easily support local consumers’ health goals.” 

Carnipure® L-Carnitine supports many life stages

Popular as a sports nutrition supplement ingredient, Carnipure® L-Carnitine also provides beneficial support across many life stages and applications, including infant nutrition, prenatal health, male fertility, cardiovascular health, energy, healthy aging and weight management.

Heat- and pH-stable, and highly water soluble, Carnipure® L-Carnitine is easy to integrate into formulas for dietary supplements, beverages, bars, dairy and other food products.  

High quality, guaranteed

The Carnipure® brand and quality seal stand for more than 30 years of expertise and a proven reputation in the production of quality products. Combined with its excellent safety profile and full traceability, Carnipure® L-Carnitine offers manufacturers an efficacious solution to support consumer needs. 

More information is available on the following websites:

www.carnipure.com / www.lonza.com  

About Lonza

Lonza is an integrated solutions provider that creates value along the Healthcare Continuum®. Through our Lonza Pharma Biotech & Nutrition segment and our Lonza Specialty Ingredients segment businesses, we harness science and technology to serve markets along this continuum. We focus on creating a healthy environment, promoting a healthier lifestyle and preventing illness through consumers' preventive healthcare, as well as improving patient healthcare by supporting our customers to deliver innovative medicines that help treat or even cure severe diseases.

Patients and consumers benefit from our ability to transfer our pharma know-how to the healthcare, hygiene and fast-moving consumer goods environment and to the preservation and protection of the world where we live.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 15,500 full-time employees worldwide at the end of 2018. The company generated sales of CHF 5.5 billion in 2018 with a CORE EBITDA of CHF 1.5 billion. Further information can be found at www.lonza.com.


Lonza Contact Details

Dirk Oehlers, Head Investor Relations
Lonza Group Ltd
Tel +41 61 316 8540

Constance Ward, Head External Communications
Lonza Group Ltd
Tel +41 61 316 8840